Shire PLC (NASDAQ:SHPG)

126.05
Delayed Data
As of Feb 22
 +1.02 / +0.82%
Today’s Change
123.73
Today|||52-Week Range
192.15
-18.74%
Year-to-Date
John Paulson Invests in Entertainment Stocks in 4th Quarter
Feb 21 / GuruFocus News - Paid Partner Content
Shire (SHPG) Q4 Earnings Beat, Immunology Franchise Strong
Feb 15 / Zacks.com - Paid Partner Content
John Paulson Invests in Entertainment in 4th Quarter
Feb 20 / GuruFocus News - Paid Partner Content
Shire (SHPG) to Report Q4 Earnings: What's in the Cards?
Feb 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close125.03
Today’s open125.98
Day’s range125.74 - 127.63
Volume1,276,203
Average volume (3 months)1,290,980
Market cap$37.9B
Data as of 4:15pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+13.50%
Earnings growth (next 5 years)+8.03%
Revenue growth (last year)+76.71%
P/E ratio9.0
Price/Sales3.89
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.30-0.19%
REGNRegeneron Pharmaceut...-1.69-0.53%
BAXBaxter International...+0.38+0.57%
ALXNAlexion Pharmaceutic...-2.51-2.14%
Data as of 4:15pm ET, 02/22/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)$3.84
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO &
Independent Non-Executive Director
Dominic Blakemore
Chief Financial Officer
John Miller
Corporate headquarters
Dublin, Dublin

Forecasts